| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
| This economic area has recently experienced notable investment growth, driven by advancements in cancer treatment and biotherapeutics. Significant stock movements have been observed, particularly with key firms like Novavax and CRISPR showcasing positive earnings surprises. The integration of AI infrastructure into biotechnology is also contributing to its momentum, indicating a robust future. However, the market seems sensitive to stock rotations that could affect its overall perception. The price action of Small Biotechnology (XBI) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The trend sentiment at 0.7 is bullish. The market sentiment at -0.8 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for XBI since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for Small Biotechnology sector is at 0.1, and the negative at -0.9 on 2026-02-27. The forces of Market Risk Appetite (-2.1), Option Sentiment (-1.5), Sentiment towards Fundamentals (-1), Valuation Sentiment (-0.5), and Broad Market Trend (-0.1) will drive down the price. The forces of Price Level Sentiment (0), and Sector Price Trend (0.7) will drive up the price. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XBI trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice Sector Rotation Notification
| XBI | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 1%(0.7%) | 127.35 | 1.55% | 71 | -0.26% | 0.32% | 0.7 | -0.1 | 0.7% | -0.8 | Wait | 50% | -1 | 0 |
| 2026-02-26 | 1%(0.7%) | 127.69 | 1.53% | 75 | -0.48% | 0.24% | 0.5 | 0.2 | 1% | -0.8 | Long | 55% | -1 | 4.2 |
| 2026-02-25 | 1%(0.6%) | 128.3 | 1.48% | 86 | -0.64% | 0.24% | 0.6 | -0.2 | 0.8% | -0.4 | Wait | 50% | -1 | 6.3 |
| 2026-02-24 | 1%(0.6%) | 129.13 | 1.49% | 96 | 1.73% | 0.24% | 0.9 | 0.5 | 1.3% | -1.1 | Wait | 50% | -1 | 7.2 |
| 2026-02-23 | 1%(0.6%) | 126.94 | 1.43% | 68 | 1.67% | 0.16% | 0.8 | 0.2 | 0.8% | -0.9 | Long | 55% | -1 | 1.5 |
| 2026-02-22 | 0%(0.4%) | 0.3 | -0.3 | -1 | -0.5 | |||||||||
| 2026-02-21 | 0%(0.4%) | 0.3 | -0.3 | -1 | -4.5 | |||||||||
| 2026-02-20 | 1%(0.4%) | 124.86 | 1.51% | 40 | -1.48% | 0.32% | 0.3 | -0.2 | 0.6% | -0.5 | Short | 55% | -1 | -3.9 |
| 2026-02-19 | 0%(0.4%) | 126.74 | 1.79% | 58 | 0.9% | 0.08% | 0.4 | 0.4 | 0.5% | -1 | Long | 55% | -1 | 7.5 |
| 2026-02-18 | 1%(0.6%) | 125.61 | 1.84% | 46 | 0.72% | -0.16% | -0.1 | 0 | 0.8% | -1.2 | Long | 55% | -1 | 3.5 |
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Market News | ||
| 1 (8) Generate Biomedicines Prices IPO At $16/shr Generate Biomedicines, Inc. (GENB) on Thursday priced its initial public offering of 25,000,000 shares of stock at $16 per share, raising gross proceeds of $400 million. (https://www.rttnews.com/) Fri. Feb 27, 2026 | ||
| 2 (0) Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX Weekly buzz article covers crucial milestones in the biotech space ,covering regulatory approvals, rejections, mergers, deals and major phase 2 and 3 clinical trial results in the week. (https://www.rttnews.com/) Fri. Feb 27, 2026 | ||
| 3 (-4) Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut Feb 27 () - Flagship-backed Generate Biomedicines' shares fell 6.25% in its Nasdaq debut on Friday, giving the drug developer a valuation of $1. (https://finance.yahoo.com/) Fri. Feb 27, 2026 | ||
| 4 (-5) Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus. (https://www.benzinga.com/) Fri. Feb 27, 2026 | ||
| 5 (-4) Why Are Shares Of Xeris Biopharma Falling Friday? Xeris Biopharma Holdings shares are falling Friday after the company announced a patent infringement lawsuit to protect its drug, Recorlev. (https://www.benzinga.com/) Fri. Feb 27, 2026 | ||
| 6 (8) OneMedNet Stock Skyrockets As It Rolls Out Next RWD Phase With Palantir Foundry OneMedNet shares jump after it advances the commercial rollout of its Palantir Foundry-powered real-world data platform and pushes customer trials toward recurring subscriptions. (https://www.benzinga.com/) Fri. Feb 27, 2026 | ||
| 7 (8) Can Growing Patient And Provider Adoption Of Neffy Propel ARS Pharma's Stock Upward? ARS Pharmaceuticals Inc.'s (SPRY) flagship product, neffy, has been enjoying strong commercial growth since launch, helped by growing patient awareness and increasing clinician confidence in its efficacy. (https://www.rttnews.com/) Thu. Feb 26, 2026 | ||
| 8 (2) Grail’s Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. The diagnostics company’s stock climbed fivefold last year, but it dropped in half Friday. (https://www.barrons.com/) Thu. Feb 26, 2026 | ||
| 9 (8) Why Is CRISPR Therapeutics Stock Surging Thursday? CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased patient treatment and analyst confidence. (https://www.benzinga.com/) Thu. Feb 26, 2026 | ||
| 10 (7) COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb Novavax shares jump 21% after posting a surprise profit and 67% revenue growth, while outlining lower 2026 revenue guidance. (https://www.benzinga.com/) Thu. Feb 26, 2026 | ||
| 11 (7) Money Is Rotating — And This Biotech Medical Play Is Hard to Ignore This small-cap stock, which has nothing to do with AI disruption, is exactly the kind I look for in a rotational market. (https://www.thestreet.com/) Thu. Feb 26, 2026 | ||
| 12 (8) The Startup Building An Operating System For Biotech AI Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype. (https://www.forbes.com/) Thu. Feb 26, 2026 | ||
| 13 (-7) Sarepta CEO To Jump Ship After 'Tumultuous' Year Sarepta stock drops after a wider loss, Elevidys sales fall 33%, and CEO retirement plans add fresh uncertainty for investors. (https://www.benzinga.com/) Thu. Feb 26, 2026 | ||
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA